Cencora price target raised to $280 from $265 at Citi

Citi raised the firm’s price target on Cencora to $280 from $265 and keeps a Buy rating on the shares. The analyst remains generally positive on the distributors heading into the Q1 reports, but cautions that this will be a difficult quarter from a comp perspective. Namely, GLP-1 growth will slow materially and the distributors will see limited benefit from commercial COVID vaccines, the analyst tells investors in a research note.